1. Catalog
  2. Primary Prevention of Cardiovascular Disease in Wo ...
Image For Activity Cover
Primary Prevention of Cardiovascular Disease in Women
Course Description
 
Accreditation and Designation Statements
 
Learning Objectives
 
Target Audience
 
Disclosures and Conflicts of Interest
 
Commercial Support
 
List of Faculty
 
Disclaimer
 
Number of Faculty Members
 
Number of Lectures
 
Engaged Member Price
 
Informed Member Price
 
Non-Member Price
 
Purchase URL
https://my.aace.com/manage-subscriptions
Faculty
Leslie Cho, MD
Cardiology
Cleveland Clinic 

Leslie Cho, MD, is Director of the Cleveland Clinic’s Women’s Cardiovascular Center. She is also Section Head, Preventive Cardiology and Rehabilitation and Chief Quality Officer in the Robert and Suzanne Tomsich Department of Cardiovascular Medicine at Cleveland Clinic. She is a Professor of Medicine at Cleveland Clinic Lerner School of Medicine Case Western Reserve Medical School. She is on the Cardiovascular Committee for National Quality Forum and is a special consultant to the FDA. She has been on the steering committee for clinical trials and is currently the Co-PI for Lp(a) Horizon study. She is the chair-elect for ACC CVD in women’s group. Dr. Cho is board-certified in interventional cardiology, cardiovascular medicine, and internal medicine. 
Accreditation Information

Accreditation and Designation Statements:

The American College of Endocrinology designates this enduring activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Maintenance of Certification

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.0 MOC Medical Knowledge point(s) in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC point(s) equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit. Aggregate participant data will be shared with commercial supporters of this activity.

Learning Objectives

Through this education, learners will improve their abilities to:

    • Identify unique cardiovascular risk factors in women
    • Discuss gender disparities in cardiovascular care
    • Describe unique cardiovascular disease in women. Women have unique cardiovascular disease – for example, stress-induced cardiomyopathy is a very female-specific CVD as well as microvessel disease as coronary artery dissection

Target Audience

This educational initiative is intended for all members of the endocrine care team.

Disclosure and Conflicts of Interest

Disclosure Policy

In accordance with the ACCME Standards for Commercial Support, The American Association of Clinical Endocrinology (AACE)requires that individuals in a position to control the content of an educational activity disclose all relevant financial relationships with any commercial interest. AACE resolves all conflicts of interest to ensure independence, objectivity, balance, and scientific rigor in all their educational programs. Furthermore, AACE seeks to verify that all scientific research referred to, reported, or used in a CME/CE activity conforms to the generally accepted standards of experimental design, data collection, and analysis. AACE is committed to providing learners with high-quality CME.

Faculty​

  • Leslie Cho, MD
    Nothing to disclose

Disclosure of Unlabeled Use

AACE requires CME faculty (speakers) to disclose when products or procedures being discussed are off label, unlabeled, experimental and/or investigational, and any limitations on the information that is presented, such as data that are preliminary, or that represent ongoing research, interim analyses, and/or unsupported opinion. Faculty in this activity may discuss information about pharmaceutical agents that is outside of US Food and Drug Administration approved labeling. This information is intended solely for continuing medical education and is not intended to promote off-label use of these medications. AACE does not recommend the use of any agent outside of the labeled indications. If you have questions, contact the Medical Affairs Department of the manufacturer for the most recent prescribing information.
Summary
Availability: Retired
Cost: FREE
Credit Offered:
No Credit Offered
Powered By